Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dosimetry of solid tumors

R F Meredith1, T K Johnson, G Plott

  • 1Department of Radiation Oncology, University of Alabama, Birmingham 35233.

Medical Physics
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1.

Oncogene·2024
Same author

Squirrelpox in a red squirrel in Fife.

The Veterinary record·2024
Same author

Tissue microarray (TMA) use in post mortem neuropathology.

Journal of neuroscience methods·2020
Same author

Microbiological Quality of Commercial Tofu.

Journal of food protection·2019
Same author

Buccal glands of adults of the lamprey Mordacia mordax, including comparisons with other species.

Journal of morphology·2018
Same author

The junction zone: Initial site of mineralization in radula teeth of the chiton Cryptoplax striata (Mollusca: Polyplacophora).

Journal of morphology·2018
Same journal

Correction to "On the shape of the radiation survival curve in tumor spheroids: The role of oxygen heterogeneity".

Medical physics·2026
Same journal

Multi-view constrained semi-supervised vertebra detection for 3D ultrasound spine volume.

Medical physics·2026
Same journal

Accuracy of quantitative <sup>177</sup>Lu SPECT/CT imaging: A systematic review.

Medical physics·2026
Same journal

Physics-constrained dual-domain network for CBCT reconstruction from orthogonal X-rays in gynecologic radiotherapy.

Medical physics·2026
Same journal

Decomposition-based harmonization for quantitative PET imaging across scanners and radiotracers.

Medical physics·2026
Same journal

Development and evaluation of an in vivo dose-based monitoring system for electron FLASH radiation therapy.

Medical physics·2026
See all related articles

Radioimmunotherapy dosimetry research over ten years is summarized. Future solid tumor dosimetry may incorporate non-uniform activity and cell-level data for improved accuracy.

Area of Science:

  • Medical Physics
  • Nuclear Medicine
  • Oncology

Background:

  • Radioimmunotherapy (RAIT) involves administering radioactive antibodies to target cancer cells.
  • Accurate dosimetry is crucial for effective RAIT and minimizing side effects.
  • Existing dosimetry methods face challenges with complex tumor geometries and activity distributions.

Purpose of the Study:

  • To summarize a decade of RAIT dosimetry data and methodologies.
  • To discuss the application and limitations of the MIRD methodology for solid tumors.
  • To explore future directions in solid tumor dosimetry.

Main Methods:

  • Review of dosimetry data from ten years of RAIT studies.
  • Application of the MIRD (Medical Internal Radiation Dose) methodology.

Related Experiment Videos

  • Investigation of approaches for non-standard tumor geometries and inhomogeneous activity distribution.
  • Main Results:

    • The MIRD methodology is generally applicable but has limitations for solid tumors.
    • Current dosimetry often assumes homogeneous activity distribution for practicality.
    • Future dosimetry may involve absorbed fractions for individual tumors and cellular-level data.

    Conclusions:

    • Solid tumor dosimetry requires addressing non-standard geometries and inhomogeneous activity.
    • The "average dose" may be replaced by statistical distributions reflecting viable cell counts.
    • Tumor control dose estimates may evolve based on cell sterilization thresholds.